Search research articles
Contact Us
Filters
Showing results (11-20 of 115) with videos related to
Page
of 12
Sort By:
Drugs of Today (Barcelona, Spain : 1998)
|
August 31, 2007
Pioglitazone and metformin
Nathan R Hill, David R Matthews
Diabetes Care
|
July 25, 2015
Response to Comments on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149
Silvio E Inzucchi, David R Matthews,
The New England Journal of Medicine
|
November 23, 2017
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal, Vlado Perkovic, David R Matthews
Circulation
|
October 26, 2018
Letter by Matthews et al Regarding Article, "Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist"
David R Matthews, Vlado Perkovic, Kenneth W Mahaffey
Diabetes
|
October 31, 2008
An appreciation of Robert Turner
Stephen O'Rahilly, Gordon C Weir, David R Matthews
Diabetes Care
|
May 27, 2004
Use and abuse of HOMA modeling
Tara M Wallace, Jonathan C Levy, David R Matthews
Diabetes Care
|
April 9, 2013
Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2
Nathan R Hill, Jonathan C Levy, David R Matthews
Journal of Diabetes Science and Technology
|
June 14, 2013
Methodology for quantifying fasting glucose homeostasis in type 2 diabetes: observed variability and lability
Nathan R Hill, Apostolos Tsapas, Peter Hindmarsh, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
February 14, 2019
The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm
Viswanathan Mohan, Mark E Cooper, David R Matthews, et al.
Annals of Internal Medicine
|
January 18, 2021
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes
Apostolos Tsapas, Thomas Karagiannis, Ioannis Avgerinos, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 115) with videos related to
Sort By:
Page
of 12
Drugs of Today (Barcelona, Spain : 1998)
|
August 31, 2007
Pioglitazone and metformin
Nathan R Hill, David R Matthews
Diabetes Care
|
July 25, 2015
Response to Comments on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149
Silvio E Inzucchi, David R Matthews,
The New England Journal of Medicine
|
November 23, 2017
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal, Vlado Perkovic, David R Matthews
Circulation
|
October 26, 2018
Letter by Matthews et al Regarding Article, "Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist"
David R Matthews, Vlado Perkovic, Kenneth W Mahaffey
Diabetes
|
October 31, 2008
An appreciation of Robert Turner
Stephen O'Rahilly, Gordon C Weir, David R Matthews
Diabetes Care
|
May 27, 2004
Use and abuse of HOMA modeling
Tara M Wallace, Jonathan C Levy, David R Matthews
Diabetes Care
|
April 9, 2013
Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2
Nathan R Hill, Jonathan C Levy, David R Matthews
Journal of Diabetes Science and Technology
|
June 14, 2013
Methodology for quantifying fasting glucose homeostasis in type 2 diabetes: observed variability and lability
Nathan R Hill, Apostolos Tsapas, Peter Hindmarsh, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
February 14, 2019
The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm
Viswanathan Mohan, Mark E Cooper, David R Matthews, et al.
Annals of Internal Medicine
|
January 18, 2021
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes
Apostolos Tsapas, Thomas Karagiannis, Ioannis Avgerinos, et al.
Page
of 12